Provider Administered Drugs – Preferred Products – Commercial Medical Benefit Drug Policyopen_in_new

UnitedHealthcare covers the listed Sandoz treprostinil injection formulations as the preferred medical‑benefit products for indicated diagnoses and requires members new to therapy to use a preferred product. Non‑preferred treprostinil is only payable if there is documented intolerance or contraindication to a preferred product with physician attestation that the same adverse event would not be expected with the non‑preferred product, and coverage is subject to diagnosis‑specific criteria, the member’s benefit plan, and applicable state/federal mandates.

"Coverage will be provided for the UnitedHealthcare preferred product contingent on the coverage criteria in the Diagnosis-Specific Criteria section."

Sign up to see full coverage criteria, indications, and limitations.